News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

NeuBase Therapeutics Announces Receipt of Notice from Nasdaq

NeuBase Therapeutics, ABVC BioPharma, Stoke Therapeutics among healthcare movers [Seeking Alpha]

Form DEF 14A NeuBase Therapeutics, For: May 13

Form 8-K NeuBase Therapeutics, For: Apr 04

Form PRE 14A NeuBase Therapeutics, For: May 13

Form 8-K NeuBase Therapeutics, For: Mar 05

Form 8-K NeuBase Therapeutics, For: Feb 22

Top News Decliners

7/15 NeuBase Therapeutics Initiates Trading on NASDAQ Under Ticker Symbol “NBSE” -20.9%

7/16 Form 3 NeuBase Therapeutics, For: Jul 12 Filed by: Stephan Dietrich A -11.2%

9/24 Form EFFECT NeuBase Therapeutics, -10.7%

11/20 NeuBase Therapeutics (NASDAQ: NBSE) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $14.00 price target on the stock. -9.1%

1/10 Form 10-K NeuBase Therapeutics, For: Sep 30 -7.5%

4/1 NeuBase Therapeutics (NASDAQ: NBSE) had its price target raised by analysts at Oppenheimer Holdings Inc. from $14.00 to $17.00. They now have an "outperform" rating on the stock. -7.1%

4/23 NeuBase Therapeutics (NASDAQ: NBSE) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -7.0%

4/27 NeuBase Therapeutics Announces Proposed Public Offering of Common Stock -7.0%

3/30 ROTH Capital Partners Honored by Global M&A Network -5.6%

2/21 NeuBase Therapeutics Receives Notification of Deficiency from Nasdaq Related to Delayed Quarterly Report on Form 10-Q -5.6%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}